List of Tables
Table 1. Global Anti-PD-1 MAb Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of 1mg
Table 3. Key Players of 2.5mg
Table 4. Key Players of Others
Table 5. Global Anti-PD-1 MAb Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti-PD-1 MAb Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Anti-PD-1 MAb Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Anti-PD-1 MAb Market Share by Region (2020-2025)
Table 9. Global Anti-PD-1 MAb Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Anti-PD-1 MAb Market Share by Region (2026-2031)
Table 11. Anti-PD-1 MAb Market Trends
Table 12. Anti-PD-1 MAb Market Drivers
Table 13. Anti-PD-1 MAb Market Challenges
Table 14. Anti-PD-1 MAb Market Restraints
Table 15. Global Anti-PD-1 MAb Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Anti-PD-1 MAb Market Share by Players (2020-2025)
Table 17. Global Top Anti-PD-1 MAb Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-PD-1 MAb as of 2024)
Table 18. Ranking of Global Top Anti-PD-1 MAb Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Anti-PD-1 MAb Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Anti-PD-1 MAb, Headquarters and Area Served
Table 21. Global Key Players of Anti-PD-1 MAb, Product and Application
Table 22. Global Key Players of Anti-PD-1 MAb, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-PD-1 MAb Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Anti-PD-1 MAb Revenue Market Share by Type (2020-2025)
Table 26. Global Anti-PD-1 MAb Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Anti-PD-1 MAb Revenue Market Share by Type (2026-2031)
Table 28. Global Anti-PD-1 MAb Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Anti-PD-1 MAb Revenue Market Share by Application (2020-2025)
Table 30. Global Anti-PD-1 MAb Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Anti-PD-1 MAb Revenue Market Share by Application (2026-2031)
Table 32. North America Anti-PD-1 MAb Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Anti-PD-1 MAb Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Anti-PD-1 MAb Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Anti-PD-1 MAb Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Anti-PD-1 MAb Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Anti-PD-1 MAb Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Anti-PD-1 MAb Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Anti-PD-1 MAb Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Anti-PD-1 MAb Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Anti-PD-1 MAb Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Anti-PD-1 MAb Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Anti-PD-1 MAb Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Anti-PD-1 MAb Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Anti-PD-1 MAb Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Anti-PD-1 MAb Product
Table 50. Thermo Fisher Scientific Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. OriGene Technologies Company Details
Table 53. OriGene Technologies Business Overview
Table 54. OriGene Technologies Anti-PD-1 MAb Product
Table 55. OriGene Technologies Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 56. OriGene Technologies Recent Development
Table 57. Elabscience Company Details
Table 58. Elabscience Business Overview
Table 59. Elabscience Anti-PD-1 MAb Product
Table 60. Elabscience Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 61. Elabscience Recent Development
Table 62. Leinco Technologies Company Details
Table 63. Leinco Technologies Business Overview
Table 64. Leinco Technologies Anti-PD-1 MAb Product
Table 65. Leinco Technologies Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 66. Leinco Technologies Recent Development
Table 67. Sino Biological Company Details
Table 68. Sino Biological Business Overview
Table 69. Sino Biological Anti-PD-1 MAb Product
Table 70. Sino Biological Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 71. Sino Biological Recent Development
Table 72. Ximbio Company Details
Table 73. Ximbio Business Overview
Table 74. Ximbio Anti-PD-1 MAb Product
Table 75. Ximbio Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 76. Ximbio Recent Development
Table 77. Merck KGaA Company Details
Table 78. Merck KGaA Business Overview
Table 79. Merck KGaA Anti-PD-1 MAb Product
Table 80. Merck KGaA Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 81. Merck KGaA Recent Development
Table 82. BioVision Company Details
Table 83. BioVision Business Overview
Table 84. BioVision Anti-PD-1 MAb Product
Table 85. BioVision Revenue in Anti-PD-1 MAb Business (2020-2025) & (US$ Million)
Table 86. BioVision Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Anti-PD-1 MAb Picture
Figure 2. Global Anti-PD-1 MAb Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-PD-1 MAb Market Share by Type: 2024 VS 2031
Figure 4. 1mg Features
Figure 5. 2.5mg Features
Figure 6. Others Features
Figure 7. Global Anti-PD-1 MAb Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Anti-PD-1 MAb Market Share by Application: 2024 VS 2031
Figure 9. Pharmaceutical Case Studies
Figure 10. Research Case Studies
Figure 11. Other Case Studies
Figure 12. Anti-PD-1 MAb Report Years Considered
Figure 13. Global Anti-PD-1 MAb Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Anti-PD-1 MAb Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti-PD-1 MAb Market Share by Region: 2024 VS 2031
Figure 16. Global Anti-PD-1 MAb Market Share by Players in 2024
Figure 17. Global Top Anti-PD-1 MAb Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-PD-1 MAb as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Anti-PD-1 MAb Revenue in 2024
Figure 19. North America Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Anti-PD-1 MAb Market Share by Country (2020-2031)
Figure 21. United States Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti-PD-1 MAb Market Share by Country (2020-2031)
Figure 25. Germany Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti-PD-1 MAb Market Share by Region (2020-2031)
Figure 33. China Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-PD-1 MAb Market Share by Country (2020-2031)
Figure 41. Mexico Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti-PD-1 MAb Market Share by Country (2020-2031)
Figure 45. Turkey Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Anti-PD-1 MAb Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 49. OriGene Technologies Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 50. Elabscience Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 51. Leinco Technologies Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 52. Sino Biological Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 53. Ximbio Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 54. Merck KGaA Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 55. BioVision Revenue Growth Rate in Anti-PD-1 MAb Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
